《Lancet,3月25日,The official French guidelines to protect patients with cancer against SARS-CoV-2 infection》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-03-26
  • The official French guidelines to protect patients with cancer against SARS-CoV-2 infection

    Benoit You

    Alain Ravaud,Anne Canivet,Gérard Ganem,Philippe Giraud,Rosine Guimbaud

    Published:March 25, 2020DOI:https://doi.org/10.1016/S1470-2045(20)30204-7

    On request of the French Health Ministry, the French High Council for Public health (Haut Conseil de Santé Publique [HCSP]) entrusted a representative group of French medical oncologists and radiation oncologists, working across academic and private practice, with the task of preparing guidelines to protect patients with cancer against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, while maintaining the possibility of cancer treatment.

  • 原文来源:https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30204-7/fulltext
相关报告
  • 《LANCET,3月17日,Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-18
    • Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis Yong Xiao Hong Pan Qian She Fen Wang Mingkai Chen Published:March 17, 2020DOI:https://doi.org/10.1016/S2468-1253(20)30080-7 We read the Comment by Chao Zhang and colleagues1 in The Lancet Gastroenterology & Hepatology on liver injury in coronavirus disease 2019 (COVID-19) with great interest. Given that patients with decompensated cirrhosis have a higher risk of, and mortality from, infection, preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in this patient population is a challenging task.2 We provide our experience of COVID-19 prevention in patients with decompensated cirrhosis in Wuhan, China.
  • 《LANCET,3月3日,Guidelines for pregnant women with suspected SARS-CoV-2 infection》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-04
    • Guidelines for pregnant women with suspected SARS-CoV-2 infection Guillaume Favre, Léo Pomar, Xiaolong Qi, Karin Nielsen-Saines, Didier Musso, David Baud Published:March 03, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30157-2 Coronaviruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) can cause severe adverse pregnancy outcomes, such as miscarriage, premature delivery, intrauterine growth restriction, and maternal death. Vertical transmission of the virus responsible for 2019 novel coronavirus disease (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has not yet been detected, whereas perinatal transmission has been suspected in one case.